SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 75 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,750,183 | -5.1% | 85,250 | +10.1% | 0.00% | 0.0% |
Q1 2024 | $1,843,548 | +10.1% | 77,460 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $1,673,911 | +48.8% | 77,460 | 0.0% | 0.00% | – |
Q3 2023 | $1,124,719 | -59.1% | 77,460 | -41.0% | 0.00% | -100.0% |
Q2 2023 | $2,748,737 | +19.6% | 131,330 | +20.7% | 0.00% | 0.0% |
Q1 2023 | $2,298,278 | -17.0% | 108,820 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $2,769,469 | +5.9% | 108,820 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $2,615,000 | +220.5% | 108,820 | +156.7% | 0.00% | – |
Q2 2022 | $816,000 | +45.5% | 42,400 | +31.3% | 0.00% | – |
Q1 2022 | $561,000 | -20.4% | 32,300 | +0.3% | 0.00% | – |
Q4 2021 | $705,000 | +14.6% | 32,200 | 0.0% | 0.00% | – |
Q3 2021 | $615,000 | +11.2% | 32,200 | 0.0% | 0.00% | – |
Q2 2021 | $553,000 | -10.1% | 32,200 | +17.1% | 0.00% | – |
Q1 2021 | $615,000 | +0.5% | 27,500 | 0.0% | 0.00% | – |
Q4 2020 | $612,000 | +23.1% | 27,500 | -18.4% | 0.00% | – |
Q3 2020 | $497,000 | -0.4% | 33,700 | 0.0% | 0.00% | – |
Q2 2020 | $499,000 | +61.0% | 33,700 | +19.1% | 0.00% | – |
Q1 2020 | $310,000 | +108.1% | 28,300 | +66.5% | 0.00% | – |
Q4 2019 | $149,000 | +17.3% | 17,000 | 0.0% | 0.00% | – |
Q3 2019 | $127,000 | -7.3% | 17,000 | +15.6% | 0.00% | – |
Q2 2019 | $137,000 | +90.3% | 14,700 | +7.3% | 0.00% | – |
Q1 2019 | $72,000 | +18.0% | 13,700 | 0.0% | 0.00% | – |
Q4 2018 | $61,000 | -45.0% | 13,700 | 0.0% | 0.00% | – |
Q3 2018 | $111,000 | +15.6% | 13,700 | 0.0% | 0.00% | – |
Q2 2018 | $96,000 | -33.8% | 13,700 | +34.3% | 0.00% | – |
Q1 2018 | $145,000 | +62.9% | 10,200 | 0.0% | 0.00% | – |
Q4 2017 | $89,000 | – | 10,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |